인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록·키워드
Salvia miltiorrhiza (S. miltiorrhiza) root contains several compounds that have a variety of physiological effects such as anti-oxidant, anti-cancer, anti-atherosclerotic, anti-inflammatory and anti-bacterial activities. S. miltiorrhiza contains diterpenoid compounds such as tanshinone Ⅰ, ⅡA and cryptotanshinone and phenolic compounds such as salvianolic acids A, B and C. The contents of major compounds, tanshinone ⅡA and cryptotanshinone, from S. miltiorrhiza were quantitatively analyzed by using high performance liquid chromatography (HPLC) to find the optimal extraction condition after the simultaneous analysis method was validated. The ROS and ONOO- scavenging assays were performed to evaluate the anti-oxidant effect of ethanol extracts from S. miltiorrhiza prepared by different extraction methods and solvents as well as tanshinone ⅡA and cryptotanshinone. The contents of tanshinone ⅡA and cryptotanshinone in extracts of S. miltiorrhiza by extraction method were the highest in immersion method with 12.255% and 7.626%. And the contents in ethanol extracts by extraction solvent were the highest in 100% ethanol with 12.407% and 8.216%. The optimized extraction condition of S. miltiorrhiza with the highest concentration of tanshinone ⅡA and cryptotanshinone was the immersion extraction method with 100% ethanol. The results showed that S. miltiorrhiza extracts by different extraction methods and solvents as well as tanshinone ⅡA and cryptotanshinone significantly have the anti-oxidant effects in a dose-dependent manner, indicating that tanshinone ⅡA and cryptotanshinone are effective major compounds for the anti-oxidation in S. miltiorrhiza. These results can be used as basic data for the standardization of products from S. miltiorrhiza and tanshinone ⅡA and cryptotanshinone can be expected to be a candidate for anti-oxidant health functional foods and herbal medicines.
본문·목차
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
최근 본 자료 전체보기
UCI(KEPA) : I410-151-25-02-092841103